Detection of lymph node metastases by gadolinium-enhanced magnetic resonance imaging: Systematic review and meta-analysis

Journal of the National Cancer Institute

Volumn 102, Issue 4, 2010, Pages 244-253

  Klerkx, Wenche M ^a   Bax, Leon ^a,b   Veldhuis, Wouter B ^a   Heintz, A Peter M ^a   Mali, Willem Pthm ^a   Peeters, Petra H M ^a   Moons, Karel G M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DATA EXTRACTION; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

CONFOUNDING FACTORS (EPIDEMIOLOGY); CONTRAST MEDIA; GADOLINIUM; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; ODDS RATIO; SENSITIVITY AND SPECIFICITY;

EID: 77649248455     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp514     Document Type: Article

References (67)

1. Haberal I, Celik H, Gocmen H, Akmansu H, Yoruk M, Ozeri C. Which is important in the evaluation of metastatic lymph nodes in head and neck cancer: palpation, ultrasonography, or computed tomography? Otolaryngol Head Neck Surg. 2004;130(2):197-201.
2. Singh K, Orakwue CO, Honest H, Balogun M, Lopez C, Luesley DM. Accuracy of magnetic resonance imaging of inguinal femoral lymph nodes in vulvar cancer. Int J Gynecol Cancer. 2006;16(3):1179-1183.
3. Kvistadt KA, Rydland J, Smethurst HB, Lundgren S, Fjosne HE, Haraldseth O. Axillary lymph node metastases in breast cancer: preopera-tive detection with dynamic contrast-enhanced MRI. Eur Radiol. 2000;10(9):1464-1471.
4. Luciani A, Dao TH, Lapeyre M, et al. Simultaneous bilateral breast and high-resolution axillary MRI of patients with breast cancer: preliminary results. AJR Am J Roentgenol. 2004;182(4):1059-1067.
5. Oellinger JJ, Blohmer JU, Michniewicz K, et al. Preoperative staging of cervical cancer: comparison of magnetic resonance imaging (MRI) and computed tomography (CT) with histologic results. Zentralbl Gynakol. 2000;122(2):82-91.
6. Will O, Purkayastha S, Chan C, et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol. 2006;7(1):52-60.
7. Anzai Y, Piccoli CW, Outwater EK, et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and effcacy study. Radiology. 2003;228(3):777-788.
8. Sharma R, Saini S, Ros PR, et al. Safety profle of ultrasmall superpara-magnetic iron oxide ferumoxtran-10: phase II clinical trial data. J Magn Reson Imaging. 1999;9(2):291-294.
9. Heesakkers RA, Hovels AM, Jager GJ, et al. MRI with a lymph-node-specifc contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol. 2008;9(9):850-856.
10. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003;3(6):453-458.
11. Lin SP, Brown JJ. MR contrast agents: physical and pharmacologic basics. J Magn Reson Imaging. 2007;25(5):884-899.
12. Degani H, Chetrit-Dadiani M, Bogin L, Furman-Haran E. Magnetic resonance imaging of tumor vasculature. Thromb Haemost. 2003;89(1):25-33.
13. Nunes LW, Schnall MD, Siegelman ES, et al. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast. AJR Am J Roentgenol. 1997;169(2):409-415.
14. Ersoy H, Rybicki FJ. Biochemical safety profles of gadolinium-based extracellular contrast agents and nephrogenic systemic fbrosis. J Magn Reson Imaging. 2007;26(5):1190-1197.
15. Goyen M, Debatin JF. Gadopentetate dimeglumine-enhanced three-dimensional MR-angiography: dosing, safety, and effcacy. J Magn Reson Imaging. 2004;19(3):261-273.
16. Peters NH, Borel Rinkes I, Zuithoff NP, Mali WP, Moons KG, Peters PH. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology. 2008;246(1):116-124.
17. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.
18. Kyzas PA, Evangelou E, axa-Kyza D, Ioannidis JP. 18F-Fluorodeoxyglu-cose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst. 2008;100(10):712-720.
19. Rockall AG, Meroni M, Song S, et al. Evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer. 2007;17(1): 188-196.
20. Chu H, Cole SR. Bivariate meta-analysis of sensitivity and specifcity with sparse data: a general linear mixed model approach. J Clin Epidemiol. 2006;59(12):1331-1332.
21. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specifcity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58(10):982-990.
22. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
23. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58(9):882-893.
24. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000;53(11):1119-1129.
25. Dwamena BA. Midas: Computational and Graphical Routines for Meta-analytical Integration of Diagnostic Accuracy Studies in Stata. Ann Arbor, MI: Division of Nuclear Medicine, Department of Radiology, University of Michigan Medical School; 2007.
26. Harbord RM. Metandi: Stata Module for Meta-analysis of Diagnostic Accuracy. Chestnut Hill, MA: Statistical Software Components, Boston College Department of Economics. Revised April 15, 2008. http://ideas. repec.org/c/boc/bocode/s456932.html. Accessed January 27, 2010.
27. Zamora J, Abraira V, Muriel A, Khan KS, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006;6:31.
28. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KGM. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol. 2006;6:50.
29. Bley TA, Uhl M, Simon P, et al. Diagnostic accuracy of MRI for preop-erative staging of pancreatic carcinoma: tendency for understaging. In Vivo. 2005;19(6):983-987.
30. Drew PJ, Farouk R, Turnball LW, Ward SC, Hartley JE, Monson JR. Preoperative magnetic resonance staging of rectal cancer with an endorectal coil and dynamic gadolinium enhancement. Br J Surg. 1999;86(2):250-254.
31. Gaa J, Wendl K, Tesdal IK, et al. Combined use of MRI and MR cholangiopancreatography and contrast enhanced dual phase 3-D MR angiography in diagnosis of pancreatic tumors: initial clinical results. Rofo. 1999;170(6):528-533.
32. Hasegawa I, Eguchi K, Kohda E, et al. Pulmonary hilar lymph nodes in lung cancer: assessment with 3D-dynamic contrast-enhanced MR imaging. Eur J Radiol. 2003;45(2):129-134.
33. Heuck A, Scheidler J, Kimmig R, et al. Lymph node staging in cervix carcinomas: the results of high-resolution magnetic resonance tomography (MRT) with a phased array body coil. Rofo. 1997;166(3):210-214.
34. Kang BC, Kim JH, Kim KW, et al. Value of the dynamic and delayed MR sequence with Gd-DTPA in the T-staging of stomach cancer: correlation with histopathology. Abdom Imaging. 2000;25(1):14-24.
35. Kaza RK, Gulati M, Wig JD, Chawla YK. Evaluation of gall bladder carcinoma with dynamic magnetic resonance imaging and magnetic resonance cholangiopancreatography. Australas Radiol. 2006;50(3):212-217.
36. Krupski G, Lorenzen J, Gawad K, Nicolas V, Izbicki JR, Adam G. MRI-based N-staging is esophageal cancer. Rofo. 2002;174(10):1269-1273.
37. Low RN, McCue M, Barone R, Saleh F, Song T. MR staging of primary colorectal carcinoma: comparison with surgical and histopathological fndings. Abdom Imaging. 2003;28(6):784-793.
38. Wallengren NO, Holtas S, Yndren-Sandberg A. Preoperative staging of rectal carcinoma using double-contrast MR imaging. Technical aspects and early clinical experiences. Acta Radiol. 1996;37(5):791-798.
39. Einspieler R, Ebner F, Posawetz W, Ranner G, Fluckiger F, Lammer J. MR-imaging with Gd-DTPA in carcinomas of tongue, oro-and hypo-pharynx. Eur J Radiol. 1991;13(1):21-26.
40. Hawighorst H, Schoenberg SO, Knapstein PG, et al. Staging of invasive cervical carcinoma and of pelvic lymph nodes by high resolution MRI with phased-array coil in comparison with pathological fndings. J Comput Assist Tomogr. 1998;22(1):75-81.
41. Hallscheidt P, Stolte E, Roeren T, Pomer S, Drehmer I, Kauffmann GW. The staging of renal-cell carcinomas in MRT and CT-a prospective histologically controlled study. Rofo. 1998;168(2):165-170.
42. Kim NK, Kim MJ, Park JK, Park SI, Min JS. Preoperative staging of rectal cancer with MRI: accuracy and clinical usefulness. Ann Surg Oncol. 2000;7(10):732-737.
43. Sheu MH, Chang CY, Wang JH, Yen MS. Preoperative staging of cervical carcinoma with MR imaging: a reappraisal of diagnostic accuracy and pitfalls. Eur Radiol. 2001;11(9):1828-1833.
44. Vorreuther R, Krestin GP, Franzen W, Engelking R, Friedmann G. Clinical value of new rapid nuclear magnetic resonance tomography in preoperative assessment of hypernephroma. A prospective comparative study of CT and MR. Urologe A. 1990;29(1):39-42.
45. Manfredi R, Mink P, Maresca G, et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology. 2004; 231(2):372-378.
46. Murray AD, Staff RT, Redpath TW, et al. Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes. Br J Radiol. 2002;75(891):220-228.
47. Okizuka H, Sugimura K, Yoshizako T, Kaji Y, Wada A. Rectal carcinoma: prospective comparison of conventional and gadopentetate dimeglumine enhanced fat-suppressed MR imaging. J Magn Reson Imaging. 1996;6(3): 465-471.
48. Barentsz JO, Jager GJ, van Vierzen PB, et al. Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. Radiology. 1996;201(1):185-193.
49. Ramsay D, Marshall M, Song S, et al. Identifcation and staging of pancreatic tumours using computed tomography, endoscopic ultrasound and mangafodipir trisodium-enhanced magnetic resonance imaging. Australas Radiol. 2004;48(2):154-161.
50. Hünerbein M, Pegios W, Rau B, Vogl TJ, Felix R, Schlag PM. Prospective comparison of endorectal ultrasound, three-dimensional endorectal ultrasound, and endorectal MRI in the preoperative evaluation of rectal tumors. Preliminary results. Surg Endosc. 2000;14(11):1005-1009.
51. Matsuoka H, Nakamura A, Masaki T, et al. Comparison between endorectal coil and pelvic phased-array coil magnetic resonance imaging in patients with anorectal tumor. Am J Surg. 2003;185(4):328-332.
52. Tempany CM, Zou KH, Silverman SG, Brown DL, Kurtz AB, McNeil BJ. Staging of advanced ovarian cancer: comparison of imaging modalities-report from the Radiological Diagnostic Oncology Group. Radiology. 2000;215(3):761-767.
53. Thurnher S, McPhillips M, von Schulthess GK, Marincek B. Cervical carcinoma staging with magnetic resonance tomography: the use of gadolinium-DOTA with 31 patients. Rofo. 1991;154(6):643-649.
54. Matsuoka H, Masaki T, Sugiyama M, et al. Gadolinium enhanced endorectal coil and air enema magnetic resonance imaging as a useful tool in the preoperative examination of patients with rectal carcinoma. Hepatogastroenterology. 2004;51(55):131-135.
55. Medl M, Kulenkampff KJ, Stiskal M, Peters-Engl C, Leodolter S, Czembirek H. Magnetic resonance imaging in the preoperative evaluation of suspected ovarian masses. Anticancer Res. 1995;15(3): 1123-1125.
56. Mumtaz H, Hall-Craggs MA, Davidson T, et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol. 1997; 169(2):417-424.
57. Krestin GP, Gross-Fengels W, Marincek B. The importance of magnetic resonance tomography in the diagnosis and staging of renal cell carcinoma. Radiologe. 1992;32(3):121-126.
58. Choi SH, Kim SH, Choi HJ, Park BK, Lee HJ. Preoperative magnetic resonance imaging staging of uterine cervical carcinoma: results of prospective study. J Comput Assist Tomogr. 2004;28(5):620-627.
59. van den Brekel MW, Castelijns JA, Croll GA, et al. Magnetic resonance imaging vs palpation of cervical lymph node metastasis. Arch Otolaryngol Head Neck Surg. 1991;117(6):663-673.
60. Kim SH, Kim SC, Choi BI, Han MC. Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. Radiology. 1994; 190(3):807-811.
61. Wide JM, White DW, Woolgar JA, Brown JS, Vaughan ED, Lewis-Jones HG. Magnetic resonance imaging in the assessment of cervical nodal metastasis in oral squamous cell carcinoma. Clin Radiol. 1999;54(2):90-94.
62. Steinkamp HJ, Heim T, Schubeus P, Schorner W, Felix R. The magnetic resonance tomographic differential diagnosis between reactively enlarged lymph nodes and cervical lymph node metastases. Rofo. 1992;157(4): 406-413.
63. Yang WT, Lam WW, Yu MY, Cheung TH, Metreweli C. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR Am J Roentgenol. 2000;175(3): 759-766.
64. Kato M, Saji S, Kanematsu M, et al. Detection of lymph-node metastases in patients with gastric carcinoma: comparison of three MR imaging pulse sequences. Abdom Imaging. 2000;25(1):25-29.
65. Takashima S, Sone S, Takayama F, et al. Papillary thyroid carcinoma: MR diagnosis of lymph node metastasis. AJNR Am J Neuroradiol. 1998; 19(3):509-513.
66. Wang Q, Takashima S, Fukuda H, Takayama F, Kobayashi S, Sone S. Detection of medullary thyroid carcinoma and regional lymph node metastases by magnetic resonance imaging. Arch Otolaryngol Head Neck Surg. 1999;125(8):842-848.
67. Crisci R, Di CE, Lupattelli L, Coloni GF. MR study of N2 disease in lung cancer: contrast-enhanced method using gadolinium-DTPA. Eur J Cardiothorac Surg. 1997;11(2):214-217.